Urine test could replace repeated scans for adrenal tumors
NCT ID NCT02324647
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 807 adults with adrenal tumors found by accident during scans for other reasons. Researchers compared the usual approach of repeat CT scans to a single urine steroid profile test to see which is more cost-effective for detecting cancer. The goal is to find a simpler, cheaper way to manage these common tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simpler, more cost-effective way to diagnose adrenal tumors, reducing unnecessary scans.
- What could go wrong
- This is an observational study, not a treatment trial. The results may not change current practice if the new test is not accurate enough.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADRENAL INCIDENTALOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Medical Center Groningen
Groningen, Provincie Groningen, 9700 RB, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver tumors targeted directly: old pump, new drug
- Study aims to uncover hidden side effects of common adrenal cancer drug
- New registry aims to unlock secrets of rare adrenal cancer
- Scientists search for keys to unlock immune attack on rare adrenal cancer
- Scientists investigate adrenal tumors and seek better therapies
- New hope for rare cancers? drug combo shows promise in early trial